15 I kliniske studier med forskellige formuleringer (H5N3, H9N2 og H5N1) fik 542 personer kandidatvaccinen.
• Clinical trials In clinical trials with different formulations (H5N3, H9N2 and H5N1) 542 subjects were exposed to thecandidate vaccine.